Walleye Trading’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Walleye Trading’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20,000	Closed	-$5K	–	4835
2020 Q3	$5K	Hold	20,000	–	–	﹤0.01%	3970
2020 Q2	$9K	Hold	20,000	–	–	﹤0.01%	4087
2020 Q1	$1K	Hold	20,000	–	–	﹤0.01%	3863
2019 Q4	$3K	Buy	20,000 +5,500	+38%	+$999	﹤0.01%	4136
2019 Q3	$2K	Buy	14,500 +500	+4%	+$98	﹤0.01%	3929
2019 Q2	$3K	Hold	14,000	–	–	﹤0.01%	3924
2019 Q1	$3K	Buy	+14,000	New	+$3.53K	﹤0.01%	4069

Other funds holding NRXPW

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Walleye Trading's NRXPW Position: Q4 2020 in Review

Walleye Trading sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q4 2020, closing a stake of 20,000 shares — an estimated $5K sold.

Walleye Trading first reported a position in NRXPW in Q1 2019 and held it in 7 quarters. The position peaked at $9K in Q2 2020. 2 funds tracked by Wall St. Rank hold NRXPW as of Q4 2020.

Walleye Trading reported no remaining NRX Pharmaceuticals Warrant position as of Q4 2020 after selling out during the quarter.
Walleye Trading sold 20,000 NRX Pharmaceuticals Warrant shares in Q4 2020, an estimated $5K.
Walleye Trading first reported a position in NRX Pharmaceuticals Warrant in Q1 2019 and held it in 7 quarters.
Walleye Trading's NRX Pharmaceuticals Warrant position peaked at $9K in Q2 2020.
2 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.